|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of AlloVir (NASDAQ: ALVR) through any online brokerage.
The latest price target for AlloVir (NASDAQ: ALVR) was reported by Morgan Stanley on October 12, 2021. The analyst firm set a price target for 48.00 expecting ALVR to rise to within 12 months (a possible 97.69% upside). 5 analyst firms have reported ratings in the last year.
The stock price for AlloVir (NASDAQ: ALVR) is $24.28 last updated Wed Oct 27 2021 20:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for AlloVir.
AlloVir’s $Q3 earnings are confirmed for after-market on $November 9, 2021.
There is no upcoming split for AlloVir.
AlloVir is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.